Category: Biotechnology

08/17/2017 / / Biotechnology

Parkinson’s disease (related to the human brain cells) is one of the world’s most common long term degenerative ailments of the central nervous system that mainly affects the motor system. This causes the patients to lose dopamine neurons that are responsible for the motor control center of the brain. According to the stats from the Parkinson’s Disease Foundation, there are more than 10 million people who suffer from it worldwide with more than 60,000 cases diagnosed in the US alone.

Read the Post Reprogrammed Brain Cells to Fight Parkinson’s Disease

08/16/2017 / / Biotechnology

Once, Justin Kao during his drive was listening to the National Public Radio and heard about the latest discovery of “sweet tooth gene”. Kao is fond of eating cookies and thought to pay $5 to know if he could have that. Later, he thought that there could be millions of people who would be willing to pay bucks for revealing the tidbits in their DNA. Justin Kao, the co-founder of Helix San Francisco based company that secured $100 million in the last summer in a quest to create the first app store for genetic information.
Read the Post The DNA App Store- Helix: Sequence Once, Query Often

08/06/2017 / / Biotechnology

The multidisciplinary center of biology and engineering that is known as the scientific biology (Bio-hacking) is developing at a neck breaking pace and is opening new views that could hardly be imagined by anyone of us. In the new research, a professor of ASU’s Biodesign Institute, Alex Green, demonstrated how living cells can be induced for accomplishing the computations in the manner of computers or tiny robots.

Read the Post Bio-hacking Helping Researchers To Turn Cells Into Mini Computers

08/05/2017 / / Biotechnology

Insilico Medicine has recently signed a multi-year drug agreement with one of the biotechnology companies Juvenescence AI Limited. Juvenescence AI will be developing the first compounds that were generated by the Insilico’s deep learnings that train over structural, phenotypic, and functional data in accordance to predicting the biological activity of the compounds. The Insilico’s platforms integrate all new Artificial Intelligence techniques like the Generative Adversarial Networks in accordance to generating novel compounds with desired properties like pharmacokinetic and pharmacodynamic.

Read the Post Next-Generation Artificial Intelligence To Be Developed Into Drugs